Division of Pulmonary, Critical Care & Sleep Medicine

Kim M. Kerr, M.D.

Clinical Professor

Vice Chief, Pulmonary, Critical Care and Sleep Medicine


  1. Pulmonary vascular disease
  2. Reperfusion lung injury



  1. CTEPH
  2. Reperfusion lung injury following PTE



  1. Kerr KM, Auger WR, Fedullo PF, Channick RN, Yi ES, Moser KM. Large vessel pulmonary arteritis mimicking chronic thromboendarterectomy. Am J Respir Crit Care Med 1995; 152:367-73.
  2. Kerr KM, Auger WR, Marsh JJ, Comito RM, Kapelanski DP, Moser KM. Selectin blockade with Cy-1053 may prevent reperfusion lung injury following pulmonary thromboendarterectomy. Am J Respir Crit Care Med 1997; 155:A898.
  3. Sompradeekul S, Fedullo PF, Kerr KM, Channick RN, Auger WR. The role of pulmonary angioscopy in the preoperative assessment of patients with thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 1999; 159:A456.
  4. Archibald CJ, Auger WR, Fedullo PF, Channick RN, Kerr KM, Jamieson SW, Kapelanski DP, Watt CN, Moser KM. Long term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med 1999; 160:523-8.
  5. Auger WR, Channick RN, Kerr KM, Fedullo PF. Evaluation of patients with suspected chronic thromboembolic pulmonary hypertension. Sem Thorac Cardiovasc Surg 1999;11:179-80.
  6. Hastings RH, Auger WR, Kerr KM, Quintana RA, Deftos LJ. Parathyroid hormone-related protein and lung injury after pulmonary thromboendarterectomy. Regul Pept. 2001; 102-7.
  7. Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Current concepts: chronic thromboembolic pulmonary hypertension. N Engl J Med 2001; 345:1464-1472.
  8. Kerr KM, Rubin LJ. Epoprostenol therapy as a bridge to pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Chest 2003; 123:319-320.
  9. Kerr KM, Auger WR, Fedullo PG.  Chronic thromboembolic pulmonary hypertension; when to suspect it, when to refer for surgery. Advances in Pulmonary Hypertension 2003;2:4-8  
  10. Bresser P, Fedullo PF, Auger WR, Channick RN, Robbins IM, Kerr KM, Jamieson SW, Rubin LJ.  Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension.   Eur Respir J 2004;23:595-600.
  11. Kerr KM.  Pulmonary artery sarcoma masquerading as chronic thromboembolic pulmonry hypertension.  Nature Clinical Practice Cardiovascular Medicine 2005;2:108-112.
  12. Lang I, Kerr K.  Risk factors for chronic thromboembolic pulmonary hypertension.  Proc Am Thorac Soc 2006;3:568-570.
  13. Auger WR, Kim NH, Kerr KM, Test VJ, Fedullo PF.  Chronic thromboembolic pulmonary hypertension. Clin Chest Med 2007;2007:255-69.
  14. Kollef MH, Afessa B, Anzueto A, Veremakis C, Kerr KM, Margolis BD, Craven DE, Roberts PR, Arroliga A, Hubmayr RD, Restrepo MI, Auger WR, Schinner R.  silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia. JAMA 2008;300:805-813.
  15. Jensen KW, Kerr KM, Fedullo PF, Kim NH, Test VJ, Ben-Yehuda O, Auger WR.  Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation 2009;120:1248-1254.
  16. Ogawa A, Firth AL, Yao W, Madani MM, Kerr KM, Auger WR, Jamieson SW, Thistlethwaite PA, Yuan JX-J. Inhibitionof mTOR attenduates store-operatid Ca 2+ entry in cells from endarterectomized tissues of patients with chronic thromboembolic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (Epub)


Board Certified:

  •   Internal Medicine
  •   Pulmonary Medicine
  •   Critical Care Medicine

San Diego Magazine's "Top Doc" in two specialties: Pulmonary Medicine and Critical Care Medicine

2016 Attending Physician of the Year- selected by UCSD Medical Staff Executive Cmte.

To schedule an appointment with Dr. Kerr, contact Sue Brick at 858-657-7132

To contact Dr. Kerr: kmkerr@ucsd.edu